Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]
A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Retrospective Data Collection for a Correlation Study Between Gastric Cancer and Clinical and Laboratory Variables
This completed study involves retrospective data collection to examine correlations between gastric cancer and a range of clinical and labor…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
A clinical trial exploring how psychological stress influences therapy efficacy and prognosis in gastric cancer and gastroesophageal junctio…
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacter Pylori [NA]
Mahidol University is conducting a clinical trial to compare gastric microbiota in patients infected with CagA-positive versus CagA-negative…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers [Phase 2]
Phase II randomized trial comparing the Bethesda Protocol to the Cambridge Method for detection of early-stage gastric cancer in CDH1 mutati…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Use of Pyrvinium to Reverse Stomach Precancerous Conditions [Phase 2]
A Phase 2 clinical trial evaluating pyrvinium to reverse stomach precancerous conditions, with recruitment not yet started.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer [Phase 3]
Phase 3 trial update on PD-1 inhibitor in combination with chemotherapy as adjuvant treatment for gastric cancer, with the study currently a…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer [Phase 1, Phase 2]
Phase Ib/II trial evaluating adebrelimab in combination with capecitabine and oxaliplatin for gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer
ClinicalTrials.gov update describing a study enrolling to evaluate small non-coding RNAs as an auxiliary diagnostic biomarker for gastric ca…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG [Phase 2]
Phase 2 trial evaluating Fruquintinib plus chemotherapy as postoperative treatment for HER2-negative gastric cancer with poor tumor regressi…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: A Propensity Score-Matched Analysis
A completed, propensity score–matched comparison of channel esophagogastrostomy versus double-tract reconstruction after laparoscopic-assist…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers [Phase 2]
This Phase 2 trial aims to evaluate whether reducing the dosing frequency of immune checkpoint inhibitors is feasible across advanced cancer…
-
CLINICAL_TRIALS approval · 2025-01-09Clinical Trial Update: International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
An international expanded-access program for ramucirumab has been established to treat metastatic gastric cancer and metastatic adenocarcino…
-
CLINICAL_TRIALS approval · 2025-01-09Clinical Trial Update: Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France
France granted a temporary authorization for use (ATU) of ramucirumab in combination with paclitaxel for gastric or gastroesophageal junctio…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia [NA]
This clinical trial update reports the EC50 of propofol required to induce loss of consciousness during general combined epidural anesthesia…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer
A multi-center real-world study is evaluating the efficacy and safety of trastuzumab-deruxtecan in advanced gastric cancer and is currently …
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer
A clinical trial update indicates that zolbetuximab is being tested in Claudin18.2-positive, HER2-negative advanced gastric cancer and is cu…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer [Phase 2]
Phase 2 trial of pre-operative adaptive short course radiation therapy for gastric cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer [Phase 2]
Phase 2 trial evaluating pre-operative or peri-operative doxorubicin regimen in patients with locally advanced, resectable gastric cancer ha…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients
A completed clinical trial from Nanjing Medical University investigated using skeletal muscle mass as a biomarker to assess frailty in older…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating tislelizumab plus the SOX regimen (S-1 and oxaliplatin) for locally advanced gastric cancer or gastroesoph…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy [NA]
A completed clinical trial evaluating whether mosapride citrate improves postoperative gastrointestinal motility after laparoscopic gastrect…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers [Phase 1, Phase 2]
This is an update on Claudin18.2-targeted CAR-T therapy CT041 for gastric and pancreatic cancers (and related digestive cancers), showing ph…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Pilot Study for High Output Drainage Removal After Gastrectomy [NA]
Pilot clinical trial evaluating high-output drainage removal after gastrectomy for gastric cancer is currently recruiting.